Searched for: in-biosketch:yes
person:rubena02
Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma
Seizinger, B R; Rouleau, G A; Ozelius, L J; Lane, A H; Farmer, G E; Lamiell, J M; Haines, J; Yuen, J W; Collins, D; Majoor-Krakauer, D; Rubenstein, AE; Halperin, J
Von Hippel-Lindau disease (VHL) is an autosomal dominant disorder with inherited susceptibility to various forms of cancer, including hemangioblastomas of the central nervous system, phaeochromocytomas, pancreatic malignancies, and renal cell carcinomas. Renal cell carcinomas constitute a particularly frequent cause of death in this disorder, occurring as bilateral and multifocal tumours, and presenting at an earlier age than in sporadic, non-familial cases of this tumour type. We report here that the VHL gene is linked to the locus encoding the human homologoue of the RAF1 oncogene, which maps to chromosome 3p25 (ref. 4). Crossovers with the VHL locus suggest that the defect responsible for the VHL phenotype is not a mutation in the RAF1 gene itself. An alternative or prior event to oncogene activation in tumour formation may be the inactivation of a putative 'tumour suppressor' which can be associated with both the inherited and sporadic forms of the cancer. Sporadic renal cell carcinomas have previously been associated with the loss of regions on chromosome 3p (refs 5, 6). Consequently, sporadic and VHL-associated forms of renal cell carcinoma might both result from alterations causing loss of function of the same 'tumour suppressor' gene on this chromosome
PMID: 2894613
ISSN: 0028-0836
CID: 102365
UNIDENTIFIED SIGNALS ON MAGNETIC RESONANCE IMAGING IN CHILDREN WITH NEUROFIBROMATOSIS [Meeting Abstract]
RUBENSTEIN A E; HUANG P; KUGLER S; WALLACE S; SASSOWER K; ARON A M; HALPERIN J
BIOSIS:PREV198834128757
ISSN: 0028-3878
CID: 102353
Clustering of severe complications in 2 kindred with Neurofibromatosis 1 [Meeting Abstract]
Rubenstein AE; Taff I; Aron A; Wallace S
ORIGINAL:0006651
ISSN: 0028-3878
CID: 102420
Optic glioma in children with NF [Meeting Abstract]
Aron A; Rubenstein AE; Wallace S
ORIGINAL:0006652
ISSN: 0364-5134
CID: 102421
Neurofibromatosis: 1977-1987 [Editorial]
Rubenstein, A E
PMID: 3107896
ISSN: 0010-6178
CID: 90856
CLUSTERING OF SEVERE COMPLICATIONS OF DISSEMINATED NEUROFIBROMATOSIS IN 2 KINDREDS [Meeting Abstract]
TAFF, I; RUBENSTEIN, AE; ARON, A; WALLACE, S; BRILL, C
ISI:A1986A889100137
ISSN: 0028-3878
CID: 102356
NEUROFIBROMATOSIS AND CHIASMAL GLIOMA - REAPPRAISAL FOR FUTURE MANAGEMENT [Meeting Abstract]
ARON, AM; TAFF, I; WALLACE, SA; RUBENSTEIN, A
ISI:A1986D933100066
ISSN: 0364-5134
CID: 102355
Neurofibromatosis
Rubenstein, Allan E; Bunge, Richard P; Housman, David E
New York NY : New York Academy of Sciences, 1986
Extent: 414 p. ; 24cm
ISBN: 0897663675
CID: 1901
Schwann-like cells cultured from human dermal neurofibromas. Immunohistological identification and response to Schwann cell mitogens
Pleasure, D; Kreider, B; Sobue, G; Ross, A H; Koprowski, H; Sonnenfeld, K H; Rubenstein, A E
Primary cultures prepared from dermal and plexiform neurofibromas contain Schwann-like cells and fibroblast-like cells. SLC are elongated and bipolar or multipolar. By indirect immunofluorescence light microscopy, living SLC bind antibodies against laminin and against nerve growth factor receptor to their surface, but not antibodies against fibronectin. In these respects, cultured SLC are indistinguishable from cultured human adult Schwann cells. FLC are flat and pleomorphic. By indirect immunofluorescence light microscopy, living FLC bind antibodies against fibronectin but not against laminin or NGFR. In these respects, cultured FLC are indistinguishable from cultured human adult endoneurial fibroblasts. Considerable purification of viable SLC from SLC/FLC mixed cultures can be achieved by flow cytofluorometry using a monoclonal anti-NGFR antibody. Tritiated thymidine radioautography indicated that mitosis of SLC in mixed SLC/FLC cultures prepared from dermal neurofibromas is infrequent in MEM with 10% calf serum, more frequent in RPMI 1640 medium with 15% fetal calf serum. Central nervous system axolemmal fragments (rat or human) elicited a greater than 10-fold SLC proliferative response in mixed SLC/FLC cultures from three of seven dermal neurofibromas (from six patients with neurofibromatosis), but had no effect on SLC mitosis in cultures from the other four dermal neurofibromas. SLC mitosis was inhibited by concentrations of cyclic adenosine 3',5'-monophosphate analogues known to stimulate proliferation of normal rat Schwann cells. Glial growth factor partially purified from bovine pituitaries stimulated SLC mitosis both in SLC/FLC mixed cultures and in cultures of purified SLC. The studies we have described indicate that neurofibroma SLC can be cultured, unequivocally identified in culture by morphological and immunohistological criteria, purified, and stimulated to proliferate by several Schwann cell mitogens. Further quantitative comparisons of the baseline and mitogen-stimulated rates of proliferation of SLC and age-matched control human Schwann cells are needed, however, to determine which of the two alternate pathogenetic mechanisms for formation of neurofibromas mentioned in the introduction is correct
PMID: 3032056
ISSN: 0077-8923
CID: 90853
Neurofibromatosis. A review of the clinical problem
Rubenstein, A E
NF is a relatively common genetic disorder which predisposes to a variety of clinical manifestations involving multiple body systems. NF poses important questions to researchers involved with developmental neurobiology, nerve regeneration and growth, the mechanism of malignant degeneration, and the use of molecular techniques to identify genetic disorders. It is hoped that this conference will bring together researchers who have developed new techniques in these areas and will encourage them to apply these techniques to the problem of NF
PMID: 3105384
ISSN: 0077-8923
CID: 90855